The Stem Cell Banking Market is being driven by Increased federal investment in stem cell therapy
The Stem Cell Banking Market is expected to grow at a CAGR of 12.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 10087.5 million. In the United States, an estimated 3.63 million babies were born in 2024, marking a 1% increase from the previous year, according to the Centers for Disease Control and Prevention (CDC). With the ease of extracting stem cells from umbilical cords compared to adult or embryonic stem cells, there has been a growing emphasis on stem cell storage initiatives by both government and corporations. The expanding knowledge base in stem cell biology has led to innovative medical intervention approaches, resulting in a surge of interest in umbilical cord blood banking. This trend is expected to significantly increase the number of patients undergoing stem cell therapies using umbilical cord blood as a graft source.
Get more information on Stem Cell Banking Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
209 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.7% |
Market growth 2025-2029 |
USD 10087.5 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
10.7 |
Key countries |
US, Canada, Germany, China, UK, France, India, Japan, Spain, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Stem Cell Banking Market encompasses the provision of stem cell processing, utilizing advanced cell culture techniques for long-term storage. Quality assurance is paramount, ensuring patient recruitment, data security, and sample tracking. Cryopreservation optimization, contamination control, and regulatory approvals are crucial. Clinical applications, research and development, and bank management software drive market growth. Automation solutions, operational efficiency, inventory management, and quality management systems enhance processes. Personnel training, risk mitigation, patient safety, and adverse event reporting prioritize patient care. Validation protocols, audit trails, compliance standards, biorepository design, database management, data analysis tools, and laboratory automation ensure market competitiveness.
The life sciences tools and services market, a segment of the larger global market, encompasses businesses specializing in Research and Development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized in the pharmaceutical and biotechnology industries for product development and laboratory diagnosis of diseases. Notably, the market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. Factors driving market growth include the increasing global population aging, with the proportion of those over 60 years projected to rise significantly. Advanced cryopreservation protocols, cell viability assays, and stem cell isolation techniques, particularly for hematopoietic stem cells, are key areas of focus in this market.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted